» Articles » PMID: 35283807

Parathyroid Imaging: Past, Present, and Future

Overview
Specialty Endocrinology
Date 2022 Mar 14
PMID 35283807
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of parathyroid imaging is to identify all sources of excess parathyroid hormone secretion pre-operatively. A variety of imaging approaches have been evaluated and utilized over the years for this purpose. Ultrasound relies solely on structural features and is without radiation, however is limited to superficial evaluation. 4DCT and 4DMRI provide enhancement characteristics in addition to structural features and dynamic enhancement has been investigated as a way to better distinguish parathyroid from adjacent structures. It is important to recognize that 4DCT provides valuable information however results in much higher radiation dose to the thyroid gland than the other available examinations, and therefore the optimal number of phases is an area of controversy. Single-photon scintigraphy with 99mTc-Sestamibi, or dual tracer 99mTc-pertechnetate and 99mTc-sestamibi with or without SPECT or SPECT/CT is part of the standard of care in many centers with availability and expertise in nuclear medicine. This molecular imaging approach detects cellular physiology such as mitochondria content found in parathyroid adenomas. Combining structural imaging such as CT or MRI with molecular imaging in a hybrid approach allows the ability to obtain robust structural and functional information in one examination. Hybrid PET/CT is widely available and provides improved imaging and quantification over SPECT or SPECT/CT. Emerging PET imaging techniques, such as 18F-Fluorocholine, have the exciting potential to reinvent parathyroid imaging. PET/MRI may be particularly well suited to parathyroid imaging, where available, because of the ability to perform dynamic contrast-enhanced imaging and co-registered 18F-Fluorocholine PET imaging simultaneously with low radiation dose to the thyroid. A targeted agent specific for a parathyroid tissue biomarker remains to be identified.

Citing Articles

Severe Headache and Deterioration of Vision in Left Eye in a Chronic Hemodialysis Patient Revealing a Brown Tumor of Sphenoid Sinus.

Esselmani H, Aimrane A, Chatoui H, El Hiba O, Najimi M, Merzouki M Neurol Int. 2025; 17(2).

PMID: 39997653 PMC: 11857977. DOI: 10.3390/neurolint17020022.


Somatostatin Receptor Imaging in the Diagnosis and Management of Parathyroid Neuroendocrine Neoplasia.

Tsoy U, Pogosian K, Ryzhkova D, Yudina O, Yakovenko K, Ryazanov P Diagnostics (Basel). 2024; 14(23).

PMID: 39682626 PMC: 11640021. DOI: 10.3390/diagnostics14232718.


Navigating diagnostic dilemmas: Localizing parathyroid adenoma in the presence of MIBI-avid thyroid nodules: A case report and literature review.

Maghsoomi Z, Rafieemanesh M, Kashanizadeh A, Boozari B, Babaei M, Hatami N Radiol Case Rep. 2024; 20(2):1041-1046.

PMID: 39678721 PMC: 11638531. DOI: 10.1016/j.radcr.2024.08.102.


Successful Localization of Recurrent MEN-1-Associated Hyperparathyroidism With 18F-Fluorocholine PET/CT.

Wootton E, Wong C, Love A, Pattison D JCEM Case Rep. 2024; 2(12):luae222.

PMID: 39659386 PMC: 11630037. DOI: 10.1210/jcemcr/luae222.


Ultrasonographic features of normal parathyroid glands confirmed during thyroid surgery in adult patients.

Kim S, Paik W, Lee J, Song Y, Yoon K, Noh B Ultrasonography. 2024; 43(5):364-375.

PMID: 39155462 PMC: 11374588. DOI: 10.14366/usg.24104.


References
1.
Goodman A, Politz D, Lopez J, Norman J . Intrathyroid parathyroid adenoma: incidence and location--the case against thyroid lobectomy. Otolaryngol Head Neck Surg. 2011; 144(6):867-71. DOI: 10.1177/0194599811400366. View

2.
Leiva-Salinas C, Flors L, Durst C, Hou Q, Patrie J, Wintermark M . Detection of parathyroid adenomas using a monophasic dual-energy computed tomography acquisition: diagnostic performance and potential radiation dose reduction. Neuroradiology. 2016; 58(11):1135-1141. DOI: 10.1007/s00234-016-1736-4. View

3.
Beland M, Mayo-Smith W, Grand D, Machan J, Monchik J . Dynamic MDCT for localization of occult parathyroid adenomas in 26 patients with primary hyperparathyroidism. AJR Am J Roentgenol. 2010; 196(1):61-5. DOI: 10.2214/AJR.10.4459. View

4.
Berman D, Maddahi J, Tamarappoo B, Czernin J, Taillefer R, Udelson J . Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. J Am Coll Cardiol. 2012; 61(4):469-477. PMC: 4316725. DOI: 10.1016/j.jacc.2012.11.022. View

5.
Christakis I, Vu T, Chuang H, Fellman B, Figueroa A, Williams M . The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma. Eur J Radiol. 2017; 95:82-88. DOI: 10.1016/j.ejrad.2017.07.026. View